401905
Goat Anti-Human IgM, μ-Chain Specific Peroxidase Conjugate
liquid, Calbiochem®
Sign Into View Organizational & Contract Pricing
All Photos(1)
UNSPSC Code:
12352203
NACRES:
NA.77
Recommended Products
biological source
goat
Quality Level
antibody form
affinity isolated antibody
antibody product type
secondary antibodies
clone
polyclonal
form
liquid
contains
0.02% thimerosal as preservative
manufacturer/tradename
Calbiochem®
storage condition
do not freeze
isotype
IgG
shipped in
wet ice
storage temp.
2-8°C
target post-translational modification
unmodified
Related Categories
General description
Immunoaffinity purified goat polyclonal antibody conjugated to horseradish peroxidase (HRP). Recognizes human IgM µ-chain.
This Goat Anti-Human IgM, µ-Chain Specific Peroxidase Conjugate is validated for use in Enzyme Immunoassay, Immunoelectrophoresis for the detection of Human IgM, µ-Chain Specific.
Application
Enzyme Immunoassay (1:10,000)
Immunoelectrophoresis (see comments)
Immunoelectrophoresis (see comments)
Packaging
Please refer to vial label for lot-specific concentration.
Warning
Toxicity: Standard Handling (A)
Physical form
In 10 mM PBS, 0.5 mM EDTA, 10% mannose, 2% sucrose, 1% BSA, pH 8.0.
Other Notes
Monospecific for human IgM µ-chain as determined by immunoelectrophoresis (IEP) against normal human serum. Variables associated with assay conditions will dictate the proper working dilution.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
To comply with ban of sale of mercury-added products required by The Interstate Mercury Education and Reduction Clearinghouse (IMERC), this product is prohibited to be sold in the following US states: Rhode Island and Connecticut.
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
André Santa Cruz et al.
Nature communications, 14(1), 1772-1772 (2023-03-31)
Several millions of individuals are estimated to develop post-acute sequelae SARS-CoV-2 condition (PASC) that persists for months after infection. Here we evaluate the immune response in convalescent individuals with PASC compared to convalescent asymptomatic and uninfected participants, six months following
Francisco J Martinez et al.
NPJ vaccines, 9(1), 10-10 (2024-01-07)
The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein (PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate invasion. A heterologous vaccine challenge trial recently showed that a delayed dosing regimen with recombinant PvDBPII SalI
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service